Has Robert Irwin, DPM received payments from drug or device companies?

Yes. Drug and device makers reported $2,524 in general payments to Robert Irwin, DPM across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Irwin, DPM did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Irwin, DPM come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Irwin, DPM

Podiatrist · Merrick, NYNPI 1093760753

Payments from drug & device makers

$2,524in general payments, 2019–2025

Across 31 payments — averaging $81.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medimetriks Pharmaceuticals, Inc.$2K
Ortho Dermatologics, A Division Of Bausch Health US, LLC$160
Journey Medical Corporation$147
Abbott$121
Glenmark Therapeutics Inc.$23
Sebela Pharmaceuticals Inc.$12

What the payments were for

Consulting fees$1,75069%
Food & beverage$77431%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medimetriks Pharmaceuticals, Inc.	19	$2,061
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$160
Journey Medical Corporation	3	$147
Abbott	1	$121
Glenmark Therapeutics Inc.	2	$23
Sebela Pharmaceuticals Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,524 in reported general payments places this provider in the 75th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York →

Medicare billing

Part B allowed, 2024

$196,374

Medicare patients

947

Services billed

2,991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	52	$12,350
Tavaborole	11	$8,194
CiclopiroxCiclopirox Olamine	102	$1,971
Ciclopirox	19	$1,558
Diclofenac Sodium	23	$889
Mupirocin	15	$118

Paid to pharmacies, not to this prescriber.

Other podiatrist in Merrick

Christopher BromleyPoughkeepsie$152K
Scott GawlikBrooklyn$77K
Waldemar MajdanskiAstoria$71K
Michael HutzelSeaford$64K
Donald RubinCorning$53K
Steven NormanMiddle Village$42K
Elvis DanneNew York$35K
Adam CirlincioneGlen Cove$31K
Jude ViolanteNiagara Falls$30K
Ammar Al RubaiayNew Hyde Park$25K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →